<p>美国食品药品监督管理局（FDA）上周对数千瓶降压药发出了全国召回，原因是发现与另一种药物交叉污染。</p>
<p>联邦监管机构于 12 月 1 日发出警告，涉及约 11,100 瓶名为 Ziac 的复合药物比索洛尔富马酸盐和氢氯噻嗪。</p>
<p>检测显示在储备样本中发现了 “微量的依泽替米贝”，这是一种用于治疗高胆固醇的处方药。</p>
<p>根据该机构的说法，此次召回被归类为三级，表明使用或接触受污染产品 “不太可能导致不良健康后果”。</p>
<p><strong>由于标签错误导致生命危险的花生过敏风险，8 个州召回 RITZ 饼干</strong></p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pills.jpg/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pills.jpg/query-dGw9MSZ2ZT0x"/></p>
<p>2014 年 4 月 9 日，高血压药片从机器中出来。（Krisztian Bocsi/Bloomberg / Getty Images）</p>
<p>总部位于新泽西州埃尔木伍德公园的 Glenmark 制药公司生产被召回的降压药片和依泽替米贝。</p>
<p>联邦监管机构表示，受影响的药片剂量为 2.5 毫克和 6.25 毫克。</p>
<p><strong>CRAYOLA 套件因 “严重伤害或死亡” 风险在全国范围内召回</strong></p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/glenmark.jpg/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/glenmark.jpg/query-dGw9MSZ2ZT0x"/></p>
<p>在这张照片插图中，Glenmark 制药公司的标志在智能手机屏幕上显示。（Piotr Swat/SOPA Images/LightRocket / Getty Images）</p>
<p>FDA 补充说，此次召回涉及 30 瓶装（NDC 68462-878-30）、100 瓶装（NDC 68462-878-01）和 500 瓶装（NDC 68462-878-05）。</p>
<p>被召回的批号的有效期从 2025 年 11 月到 2026 年 5 月不等，该机构表示。</p>
<p><strong>点击此处下载福克斯新闻应用程序</strong></p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/08/931/523/fda-hq.jpg/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/08/931/523/fda-hq.jpg/query-dGw9MSZ2ZT0x"/></p>
<p>2020 年 7 月 20 日，食品药品监督管理局的标志在马里兰州怀特奥克总部外可见。（Sarah Silbiger/Getty Images / Getty Images）</p>
<p>根据梅奥诊所的说法，比索洛尔富马酸盐和氢氯噻嗪通常一起开处方。比索洛尔有助于心脏更规律地跳动，而氢氯噻嗪则增加排尿以去除多余的钠和水。两种药物结合有助于放松血管，降低血压，并减少心脏病发作和中风的风险。</p>
<p>Glenmark 制药和 FDA 未立即回应 FOX 商业频道的评论请求。</p>

<p>美国食品药品监督管理局（FDA）已对降血压药物 Ziac 发起全国召回，原因是与胆固醇药物依泽替米贝（ezetimibe）发生了交叉污染。约有 11,100 瓶受到影响，剂量为 2.5mg 和 6.25mg。此次召回被分类为第三类，表明不太可能对健康造成不良后果。受影响药物由 Glenmark Pharmaceuticals 生产。召回影响的瓶装药物的有效期为 2025 年 11 月至 2026 年 5 月</p>

<p>The U.S. Food and Drug Administration (FDA) issued a nationwide recall of thousands of bottles of blood-pressure medication last week after discovering cross-contamination with another drug.</p>
<div class="lb-trans"><p>美国食品药品监督管理局（FDA）上周对数千瓶降压药发出了全国召回，原因是发现与另一种药物交叉污染。</p>
</div><p>Federal regulators issued the warning on Dec. 1 for roughly 11,100 bottles of the combination medication bisoprolol fumarate and hydrochlorothiazide, sold under the brand name Ziac.</p>
<div class="lb-trans"><p>联邦监管机构于 12 月 1 日发出警告，涉及约 11,100 瓶名为 Ziac 的复合药物比索洛尔富马酸盐和氢氯噻嗪。</p>
</div><p>Testing revealed that &#34;trace amounts of ezetimibe,&#34; a prescription drug used to treat high cholesterol, were detected in reserve samples.</p>
<div class="lb-trans"><p>检测显示在储备样本中发现了 “微量的依泽替米贝”，这是一种用于治疗高胆固醇的处方药。</p>
</div><p>The recall was classified as Class III, indicating that use of or exposure to the contaminated product is &#34;not likely to cause adverse health consequences,&#34; according to the agency.</p>
<div class="lb-trans"><p>根据该机构的说法，此次召回被归类为三级，表明使用或接触受污染产品 “不太可能导致不良健康后果”。</p>
</div><p><strong>RITZ CRACKERS RECALLED IN 8 STATES OVER LIFE-THREATENING PEANUT ALLERGY RISK FROM MISLABELING</strong></p>
<div class="lb-trans"><p><strong>由于标签错误导致生命危险的花生过敏风险，8 个州召回 RITZ 饼干</strong></p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pills.jpg/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pills.jpg?ve=1&amp;tl=1"/></p>
<p>High blood pressure tablets exit a machine on April 9, 2014. (Krisztian Bocsi/Bloomberg / Getty Images)</p>
<div class="lb-trans"><p>2014 年 4 月 9 日，高血压药片从机器中出来。（Krisztian Bocsi/Bloomberg / Getty Images）</p>
</div><p>Glenmark Pharmaceuticals, based in Elmwood Park, New Jersey, manufactures both the recalled blood-pressure tablets and ezetimibe.</p>
<div class="lb-trans"><p>总部位于新泽西州埃尔木伍德公园的 Glenmark 制药公司生产被召回的降压药片和依泽替米贝。</p>
</div><p>The affected pills come in 2.5-milligram and 6.25-milligram doses, according to federal regulators.</p>
<div class="lb-trans"><p>联邦监管机构表示，受影响的药片剂量为 2.5 毫克和 6.25 毫克。</p>
</div><p><strong>CRAYOLA KITS RECALLED NATIONWIDE OVER RISK OF 'SERIOUS INJURY OR DEATH’</strong></p>
<div class="lb-trans"><p><strong>CRAYOLA 套件因 “严重伤害或死亡” 风险在全国范围内召回</strong></p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/glenmark.jpg/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/glenmark.jpg?ve=1&amp;tl=1"/></p>
<p>In this photo illustration, the Glenmark Pharmaceuticals company logo is seen displayed on a smartphone screen. (Piotr Swat/SOPA Images/LightRocket / Getty Images)</p>
<div class="lb-trans"><p>在这张照片插图中，Glenmark 制药公司的标志在智能手机屏幕上显示。（Piotr Swat/SOPA Images/LightRocket / Getty Images）</p>
</div><p>The FDA added that the recall affects 30-count bottles (NDC 68462-878-30), 100-count bottles (NDC 68462-878-01) and 500-count bottles (NDC 68462-878-05).</p>
<div class="lb-trans"><p>FDA 补充说，此次召回涉及 30 瓶装（NDC 68462-878-30）、100 瓶装（NDC 68462-878-01）和 500 瓶装（NDC 68462-878-05）。</p>
</div><p>The recalled lot numbers carry expiration dates ranging from November 2025 to May 2026, the agency said.</p>
<div class="lb-trans"><p>被召回的批号的有效期从 2025 年 11 月到 2026 年 5 月不等，该机构表示。</p>
</div><p><strong>CLICK HERE TO DOWNLOAD THE FOX NEWS APP</strong></p>
<div class="lb-trans"><p><strong>点击此处下载福克斯新闻应用程序</strong></p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/08/931/523/fda-hq.jpg/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/08/931/523/fda-hq.jpg?ve=1&amp;tl=1"/></p>
<p>A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland. (Sarah Silbiger/Getty Images / Getty Images)</p>
<div class="lb-trans"><p>2020 年 7 月 20 日，食品药品监督管理局的标志在马里兰州怀特奥克总部外可见。（Sarah Silbiger/Getty Images / Getty Images）</p>
</div><p>Bisoprolol fumarate and hydrochlorothiazide are commonly prescribed together, according to Mayo Clinic. Bisoprolol helps the heart beat more regularly, while hydrochlorothiazide increases urination to remove excess sodium and water. Combined, the drugs help relax blood vessels, lower blood pressure, and reduce the risk of heart attacks and strokes.</p>
<div class="lb-trans"><p>根据梅奥诊所的说法，比索洛尔富马酸盐和氢氯噻嗪通常一起开处方。比索洛尔有助于心脏更规律地跳动，而氢氯噻嗪则增加排尿以去除多余的钠和水。两种药物结合有助于放松血管，降低血压，并减少心脏病发作和中风的风险。</p>
</div><p>Glenmark Pharmaceuticals and the FDA did not immediately respond to a request for comment from FOX Business.</p>
<div class="lb-trans"><p>Glenmark 制药和 FDA 未立即回应 FOX 商业频道的评论请求。</p>
</div>

血压药物在全国范围内被召回，FDA 发现了意外的药物混合